Clinical Trials Sponsored by Hua Medicine Limited

Total 165 results

Hua Medicine Limited

Completed

DDI Study Between Dorzagliatin and Rifampicin

Drug Interaction

China
Hua Medicine Limited

Completed

Human Mass Balance Study of HMS5552 in Healthy Subjects

Healthy Subject

United States
Hua Medicine Limited

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Hua Medicine Limited

Completed

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

Type 2 Diabetes Mellitus

China
Hua Medicine Limited

Completed

Drug Interaction Study Between Dorzagliatin and Sitagliptin

Patients

United States
Hua Medicine Limited

Completed

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers

Type 2 Diabetes Mellitus

China
Hua Medicine Limited

Completed

Drug Interaction Study Between Dorzagliatin and Empagliflozin

Patients

United States
Hua Medicine Limited

Completed

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

Drug Interaction

China
Hua Medicine Limited

Completed

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers

Type II Diabetes Mellitus

China
Hua Medicine Limited

Completed

Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM

Type 2 Diabetes Mellitus

United States
Hua Medicine Limited

Completed

Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients

Type 2 Diabetes

China
Hua Medicine Limited
Covance

Completed

Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects

Diabetes Mellitus, Type 2

China
Hua Medicine Limited
Tigermed Consulting Co., Ltd

Completed

A Multi-center 12-week Study of HMS5552 in T2DM

Diabetes Mellitus, Type 2

China
Hua Medicine Limited
Tigermed Consulting Co., Ltd

Completed

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Diabetes Mellitus, Type 2

China
HCA International Limited

Completed

Clinical and Haematological Phenotypes in Long COVID

Covid19 | Long Covid

United Kingdom
HCA International Limited

Withdrawn

Botulinum Toxin and Saliva Management in Tracheotomised Patients

Traumatic Brain Injury

United Kingdom
HCA International Limited

Terminated

Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain. (SPARE)

Metastatic Brain Cancer

United Kingdom
HCA International Limited

Unknown

Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study

Group B Streptococcus

United Kingdom
Hua Medicine Limited
Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

Recruiting

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Type2diabetes

China
Citrine Medicine Limited

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA

Excessive Daytime Sleepiness

China
LaNova Medicines Limited

Withdrawn

Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases

Relapsed or Refractory Multiple Myeloma | Other Plasma Cell Diseases
LaNova Medicines Limited

Terminated

Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

United States
LaNova Medicines Limited

Terminated

Study of LM-061 in Subjects in Advanced Tumors

Advanced Tumours

Australia
LaNova Medicines Limited

Suspended

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Malignant Tumors

China
LaNova Medicines Limited

Terminated

A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

Advanced Tumours

China
LaNova Medicines Limited

Recruiting

A Study of LM-24C5 For Advanced Solid Tumors

Advanced Solid Tumor

United States
LaNova Medicines Limited

Recruiting

Study of LM-108 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

China
LaNova Medicines Limited

Terminated

Study of LM-102 in Subjects in Advanced Tumors

Advanced Solid Tumors

United States
Immodulon Therapeutics Ltd
Theradex; HCA International Limited

Completed

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Melanoma

United Kingdom
MeiraGTx UK II Ltd
Syne Qua Non Limited

Completed

Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)

Eye Diseases | Retinal Diseases | Eye Diseases, Hereditary | Leber Congenital Amaurosis (LCA)

United States, United Kingdom
Everstar Medicines (Shanghai) Limited

Completed

A Study of Ralinepag in Healthy Chinese Adult Subjects

Healthy Volunteer | Pharmacokinetic Study

China
LaNova Australia Pty Limited

Terminated

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Australia
LaNova Australia Pty Limited

Recruiting

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

Australia
George Medicines PTY Limited

Completed

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension (GMRx2_ACT)

Hypertension

Australia, United States, United Kingdom, Poland, Sri Lanka, New Zealand, Czechia
George Medicines PTY Limited

Completed

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension (GMRx2_PCT)

Hypertension

Australia, United States, Nigeria, Sri Lanka, United Kingdom
Hue University of Medicine and Pharmacy

Completed

The Role of Micro Nutrient Supplement in Improvement of the Sperm DNA Fragmentation

Infertility, Male

Vietnam
Hue University of Medicine and Pharmacy

Completed

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

Ovulation Induction
InSilico Medicine Hong Kong Limited

Completed

A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

Idiopathic Pulmonary Fibrosis

New Zealand
University Medicine Greifswald
SDI Limited

Completed

Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth

Dentin Hypersensitivity | Active Dental Caries

Germany
InSilico Medicine Hong Kong Limited

Not yet recruiting

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited

Recruiting

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)

United States
Hue University of Medicine and Pharmacy

Recruiting

Early Treatments for Preventing Occlusal Caries Lesions

Occlusal Caries | Caries,Dental | Caries; Initial

Vietnam
InSilico Medicine Hong Kong Limited

Recruiting

Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

Healthy Subjects

Australia
InSilico Medicine Hong Kong Limited

Recruiting

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

China
Hua Zhang
Icahn School of Medicine at Mount Sinai

Completed

Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus

Viremia | Hepatitis B Infection | Chronic Infection
University of Sheffield
Ethicon Endo-Surgery; HCA International Limited; Digimed

Completed

Educational Study of Multimedia in Surgical Skills Training in Colorectal Surgery

Focus of Study: Cognitive Surgical Skill Acquisition

United Kingdom
MeiraGTx UK II Ltd
Syne Qua Non Limited; EMAS Pharma

Completed

Gene Therapy for Achromatopsia (CNGB3) (CNGB3)

Achromatopsia

United Kingdom, United States
MeiraGTx UK II Ltd
Syne Qua Non Limited; EMAS Pharma

Completed

Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

Achromatopsia

United Kingdom, United States
MeiraGTx UK II Ltd
Syne Qua Non Limited; Bionical Emas

Completed

Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)

X-Linked Retinitis Pigmentosa

United Kingdom, United States
LaNova Medicines Zhejiang Co., Ltd.

Not yet recruiting

LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Locally Advanced or Metastatic GC and GCJ Adenocarcinoma

Clinical Trials Sponsored by Hua Medicine Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations